High dose chemotherapy with haematopoietic rescue in breast cancerBEZWODA, W. R.Hematology and cell therapy (Print). 1999, Vol 41, Num 2, pp 58-65, issn 1269-3286Conference Paper

c-erb-B₂ expression and response to treatment in metastatic breast cancerBEZWODA, W. R.Medical oncology (Northwood). 2000, Vol 17, Num 1, pp 22-28, issn 1357-0560Article

Treatment of stage D2 prostatic cancer refractory to or relapsed following castration plus oestrogens : comparison of aminoglutethimide plus hdyrocortisone with mexdroxyprogesterone acetate plus hydrocortisoneBEZWODA, W. R.British journal of urology (Print). 1990, Vol 66, Num 2, pp 196-201, issn 0007-1331, 6 p.Article

In vitro maintenance of a new ovarian cancer cell line in protein-free media : a potential model for autonomous growth and tumor progressionGOLOMBICK, T; BEZWODA, W. R.European journal of cell biology. 1991, Vol 56, Num 2, pp 459-463, issn 0171-9335Article

Bisantrene in the treatment of relapsed acute non-lymphocyticBEZWODA, W. R; SEYMOUR, L.Bone marrow transplantation (Basingstoke). 1989, Vol 4, issn 0268-3369, p. 65, suppl. 3Conference Paper

Sequential α-interferon and tamoxifen : In vitro biologic effects of two growth modulatorsSEYMOUR, L; BEZWODA, W. R.International journal of oncology. 1997, Vol 10, Num 6, pp 1277-1282, issn 1019-6439Article

Positive immunostaining for platelet derived growth factor (PDGF) is an adverse prognostic factor in patients with advanced breast cancerSEYMOUR, L; BEZWODA, W. R.Breast cancer research and treatment. 1994, Vol 32, Num 2, pp 229-233, issn 0167-6806Article

The use of mitoxantrone plus cyclophosphamide as first-line treatment of metastatic breast cancerBEZWODA, W. R; HESDORFFER, C.Cancer. 1986, Vol 58, Num 8, pp 1621-1624, issn 0008-543XArticle

THE IMPORTANCE OF GASTRIC HYDROCHLORIC ACID IN THE ABSORPTION OF NONHEME FOOD IRONBEZWODA W; CHARLTON R; BOTHWELL T et al.1978; J. LAB. CLIN. MED.; USA; DA. 1978; VOL. 92; NO 1; PP. 108-116; BIBL. 21 REF.Article

Interferon plus tamoxifen treatment for advanced breast cancer : in vivo biologic effects of two growth modulatorsSEYMOUR, L; BEZWODA, W. R.British journal of cancer. 1993, Vol 68, Num 2, pp 352-356, issn 0007-0920Article

Isolation and characterisation of lactoferrin separated from human whey by adsorption chromatography using Cibacron Blue F3G-A linked affinity adsorbentBEZWODA, W. R; MANSOOR, N.Clinica chimica acta. 1986, Vol 157, Num 1, pp 89-93, issn 0009-8981Article

COMPLEX TRANSLOCATIONS INVOLVING CHROMOSOMES 15 AND 17 IN ACUTE PROMYELO-CYTIC LEUKAEMIABERNSTEIN R; HEDELOW B; PINTO MR et al.1980; BR. J. HAEMATOL.; ISSN 0007-1048; GBR; DA. 1980; VOL. 46; NO 2; PP. 311-314; BIBL. 12 REF.Article

SIGNIFICANCE OF SERUM CONCENTRATIONS OF CARCINOEMBRYONIC ANTIGEN, FERRITIN, AND CALCITONIN IN BREAST CANCERBEZWODA W; DERMAN D; BOTHWELL T et al.1981; CANCER; ISSN 0008-543X; USA; DA. 1981; VOL. 48; NO 7; PP. 1623-1628; BIBL. 23 REF.Article

TGF-β1 mRNA expression in clinical breast cancer and its relationship to ER mRNA expressionAMOILS, K. D; BEZWODA, W. R.Breast cancer research and treatment. 1997, Vol 42, Num 2, pp 95-101, issn 0167-6806Article

High-dose etoposide in treatment of metastatic breast cancerBEZWODA, W. R; SEYMOUR, L; ARIAD, S et al.Oncology. 1992, Vol 49, Num 2, pp 104-107, issn 0030-2414Article

Response to second-line hormone treatment for advanced breast cancer : predictive value of ploidy determinationSEYMOUR, L; BEZWODA, W. R; MEYER, K et al.Cancer. 1990, Vol 65, Num 12, pp 2720-2724, issn 0008-543X, 5 p.Article

Treatment of metastatic and recurrent cervix cancer with chemotherapy: a randomised trial comparing hydroxyura with cisdiamminedichloro-platinum plus methotrexateBEZWODA, W. R; NISSENBAUM, M; DERMAN, D. P et al.Medical and pediatric oncology. 1986, Vol 14, Num 1, pp 17-19, issn 0098-1532Article

Seizures after antiemetic treatment with high dose domperidone: report of four casesWEAVING, A; BEZWODA, W. R; DERMAN, D. P et al.British medical journal (1857). 1984, Vol 288, Num 6432, issn 0007-1447, 1728Article

Intraperitoneal recombinant interferon-alpha 2b for recurrent malignant ascites due to ovarian cancerBEZWODA, W. R; SEYMOUR, L; DANSEY, R et al.Cancer. 1989, Vol 64, Num 5, pp 1029-1033, issn 0008-543X, 5 p.Article

Neutrophil lactoferrin content in viral infectionsBAYNES, R. D; BEZWODA, W. R; NAZMA MANSOOR et al.American journal of clinical pathology. 1988, Vol 89, Num 2, pp 225-228, issn 0002-9173Article

Plasma exchange in the treatment of Mooren's ulcerCARMICHAEL, T. R; BEZWODA, W; RUSH, P. S et al.Annals of ophthalmology (Birmingham). 1985, Vol 17, Num 5, pp 311-314, issn 0003-4886Article

KARYOTYPE ANALYSIS IN ACUTE NONLYMPHOCYTIC LEUKEMIA (ANLL): COMPARISON WITH ETHNIC GROUP, AGE, MORPHOLOGIC, AND SURVIVALBERNSTEIN R; PINTO MR; MORCOM G et al.1982; CANCER GENET. CYTOGENET.; ISSN 0165-4608; NLD; DA. 1982; VOL. 6; NO 3; PP. 187-199; BIBL. 32 REF.Article

CYTOGENETIC FINDINGS IN CHRONIC MYELOID LEUKEMIA (CML); EVALUATION OF KARYOTYPE, BLAST MORPHOLOGY, AND SURVIVAL IN THE ACUTE PHASEBERNSTEIN R; MORCOM G; PINTO MR et al.1980; CANCER GENET. CYTOGENET.; USA; DA. 1980; VOL. 2; NO 1; PP. 23-37; BIBL. 2 P.Article

In vitro assessment of melphalan induced cytotoxicity and interstrand-DNA-cross-links in lymphocytes from patients with lymphoproliferative disorders : Correlation and mechanisms of alkylator resistance in vitro and in vivoBEZWODA, W. R; PU, Q. Q.International journal of oncology. 1997, Vol 10, Num 5, pp 1061-1068, issn 1019-6439Article

Tissue platelet derived-growth factor (PDGF) predicts for shortened survival and treatment failure in advanced breast cancerSEYMOUR, L; DAJEE, D; BEZWODA, W. R et al.Breast cancer research and treatment. 1993, Vol 26, Num 3, pp 247-252, issn 0167-6806Article